Archives - Food and Drug Administration (FDA)
FY 2004
- 09-20-2004
- Review of Food and Drug Administration's Bone Mass Study (A-03-03-00378)
FY 2002
- 02-13-2002
- Review of the Accuracy of the Food and Drug Administration's Official Establishment Inventory (A-15-01-20001)
FY 2001
- 05-03-2001
- Reporting Abuses of Persons with Disabilities (A-01-00-02502)
FY 2000
- 12-14-1999
- Review of the Food and Drug Administration's Handling of Adverse Drug Reaction Reports (A-15-98-50001)
FY 1999
- 09-01-1999
- Review of the Food and Drug Administration's Cost Increases for the Arkansas Regional Laboratory (A-15-98-50002)
FY 1998
- 07-17-1998
- Review of the Annual Reporting Process for Investigational New Drugs Regulated by the Food and Drug Administration's Center for Biologics Evaluation and Research (A-15-96-50001)
- 07-17-1998
- Review of the Food and Drug Administration's Citizen Petition Process (A-15-97-50002)
- 03-02-1998
- Review of the Food and Drug Administration's Internal Controls Over Its Purchase Card Activities (A-15-97-80002)
FY 1997
- 06-04-1997
- Review of the Food and Drug Administration's Inspection Process of Plasma Fractionators (A-03-97-00350)
- 05-16-1997
- Review of the Food and Drug Administration's Handling of Issues Related to Conjugated Estrogens (A-15-96-50002)
- 05-05-1997
- Compliance with the Prompt Payment Act by the Food and Drug Administration (A-15-96-40002)
FY 1996
- 04-12-1996
- Review of the Food and Drug Administration's Processing of 17 Error and Accident Reports Involving Blood (A-03-95-00350)
- 03-06-1996
- Review of the Food and Drug Administration's Processes to Review Medical Device Submissions Under the Pre-Market Approval and Investigational Device Exemption Programs (A-15-95-50001)
FY 1995
- 09-25-1995
- Report on the Audit of the Food and Drug Administration's Revolving Fund for Certification and Other Services for Fiscal Year 1994 (A-17-94-00040)
- 09-25-1995
- Report on the Audit of the Food and Drug Administration's Prescription Drug User Fee Account for Fiscal Year 1994 (A-17-95-00046)
- 08-02-1995
- Review of the Food and Drug Administration's Processing of a New Drug Application for Therafectin (A-15-94-00023)
- Reporting Process for Blood Establishments to Notify the Food and Drug Administration of Errors and Accidents Affecting Blood (A-03-93-00352)
FY 1994
- 09-29-1994
- Follow-up Review of Possible Improper Pre-Approval Promotion Activities (A-15-93-00018)
FY 1993
- 08-27-1993
- Financial Audit of the Food and Drug Administration's Revolving Fund for Certification and Other Services (A-15-93-00007)
- 06-07-1993
- Review of the Food and Drug Administration's Headquarters Imprest Fund (A-15-92-00019)
- 02-26-1993
- Follow-Up Review On Internal Control Weaknesses in the Food and Drug Administration's Medical Device 510(k) Review Process (A-03-92-00605)
- 10-26-1992
- Follow-up Review of the Food and Drug Administration's Generic Drug Management Information System (A-15-91-00026)
FY 1992
- 09-16-1992
- Follow-Up Review of the Food and Drug Administration's Generic Drug Approval Process (A-15-91-00025)
- 08-06-1992
- Review of Allegations of Mismanagement at the Food and Drug Administration - Newark District Office (A-02-91-02522)
- 02-21-1992
- Audit of Issues Related to the Food and Drug Administration Review of Bovine Somatotropin (A-15-90-00046)
I'm Looking For
Let's start by choosing a topic
X
Exclusions Database
Report Fraud
